Order Article Reprints

Inam S, Irfan M, Lali Nua, Khalid Syed H, Asghar S, Khan IU, Khan S-U-D, Iqbal MS, Zaheer I, Khames A, et al. Development and Characterization of Eudragit^® EPO-Based Solid Dispersion of Rosuvastatin Calcium to Foresee the Impact on Solubility, Dissolution and Antihyperlipidemic Activity. Pharmaceuticals. 2022; 15(4):492. https://doi.org/10.3390/ph15040492

Inam, Sana, Muhammad Irfan, Noor ul ain Lali, Haroon Khalid Syed, Sajid Asghar, Ikram Ullah Khan, Salah-Ud-Din Khan, Muhammad Shahid Iqbal, Imran Zaheer, Ahmed Khames, and et al. 2022. "Development and Characterization of Eudragit^® EPO-Based Solid Dispersion of Rosuvastatin Calcium to Foresee the Impact on Solubility, Dissolution and Antihyperlipidemic Activity" Pharmaceuticals 15, no. 4: 492. https://doi.org/10.3390/ph15040492

Inam, S., Irfan, M., Lali, N. u. a., Khalid Syed, H., Asghar, S., Khan, I. U., Khan, S.-U.-D., Iqbal, M. S., Zaheer, I., Khames, A., Abou-Taleb, H. A., & Abourehab, M. A. S. (2022). Development and Characterization of Eudragit^® EPO-Based Solid Dispersion of Rosuvastatin Calcium to Foresee the Impact on Solubility, Dissolution and Antihyperlipidemic Activity. Pharmaceuticals, 15(4), 492. https://doi.org/10.3390/ph15040492